Related Experiment Video

Updated: Aug 20, 2026

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
09:37

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

Published on: August 1, 2018

[Gastrointestinal bleeding in portal hypertension in liver cirrhosis]

E Biecker1, J Heller, B Appenrodt

  • 1Medizinische Klinik und Poliklinik I, Universitätsklinikum Bonn.

Zeitschrift Fur Gastroenterologie
|January 15, 2005
PubMed

Insights

Managing upper gastrointestinal bleeding in portal hypertension involves preventing first and recurrent episodes. Treatment strategies include beta-blockers, endoscopic band ligation, and transjugular intrahepatic portosystemic shunts (TIPS).

Area of Science:

  • Gastroenterology
  • Hepatology
  • Internal Medicine

Context:

  • Portal hypertension frequently leads to upper gastrointestinal bleeding, posing significant risks to patients.
  • Management strategies are crucial for preventing initial bleeding, treating active hemorrhage, and reducing recurrence.

Purpose:

  • To outline current therapeutic options for upper gastrointestinal bleeding in portal hypertensive patients.
  • To differentiate treatment approaches based on bleeding episode (first, active, recurrent) and patient condition.

Summary:

  • Primary prophylaxis for large esophageal varices involves non-selective beta-blockers or endoscopic band ligation.
  • Acute variceal bleeding requires ligation, pharmacological, and antibiotic therapy.
  • Recurrent bleeding management is individualized, considering options like shunt surgery or TIPS for specific patient groups.
  • Ectopic varices and hypertensive gastropathy necessitate tailored endoscopic, TIPS, or drug-based treatments.

Impact:

  • Provides a framework for clinicians managing complex gastrointestinal bleeding scenarios in portal hypertension.
  • Highlights the importance of individualized treatment plans based on patient-specific factors and bleeding characteristics.
  • Informs clinical practice regarding the use of pharmacological, endoscopic, and interventional radiological procedures.

More Related Videos

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension04:00

Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension

Published on: November 15, 2024

Related Concept Videos

Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is responsible...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...